Champions Oncology, INC. (CSBR) — 10-Q Filings

All 10-Q filings from Champions Oncology, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Champions Oncology Swings to Six-Month Loss Amid Rising Costs — Dec 15, 2025 Risk: high
CHAMPIONS ONCOLOGY, INC. (CSBR) reported a net income of $237,000 for the three months ended October 31, 2025, a significant decrease from $728,000 in the same
Champions Oncology Swings to Loss Amid Rising R&D Costs — Sep 15, 2025 Risk: high
CHAMPIONS ONCOLOGY, INC. reported a net loss of $466,000 for the three months ended July 31, 2025, a significant decline from the net income of $1,313,000 in th
Champions Oncology Files 10-Q for Q3 2025 — Mar 17, 2025 Risk: low
Champions Oncology, Inc. filed its 10-Q for the period ending January 31, 2025. The company, previously known as Champions Biotechnology, Inc., is in the biolog
Champions Oncology Files 10-Q for Oct 31, 2024 — Dec 16, 2024 Risk: medium
Champions Oncology, Inc. filed its 10-Q for the period ending October 31, 2024. The company, previously known as Champions Biotechnology, Inc., is in the biolog
Champions Oncology Files 10-Q — Sep 13, 2024 Risk: low
Champions Oncology, Inc. filed its 10-Q for the period ending July 31, 2024. The company, previously known as Champions Biotechnology, Inc., is in the biologica
Champions Oncology, Inc. Files 10-Q for Period Ending January 31, 2024 — Mar 15, 2024 Risk: low
CHAMPIONS ONCOLOGY, INC. (CSBR) filed a Quarterly Report (10-Q) with the SEC on March 15, 2024. Champions Oncology, Inc. filed a 10-Q report for the period endi

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX